Oliver Franklin
Direktor/Vorstandsmitglied bei JIN MEDICAL INTERNATIONAL LTD.
Aktive Positionen von Oliver Franklin
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| JIN MEDICAL INTERNATIONAL LTD. | Direktor/Vorstandsmitglied | 01.04.2023 | - |
| Independent Dir/Board Member | 01.04.2023 | - | |
| International House of Philadelphia | Corporate Officer/Principal | 25.01.2010 | - |
Dynamis Pharmaceuticals, Inc.
 Dynamis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Dynamis Pharmaceuticals, Inc. engages in the research and development of biopharmaceutical products. It develops drugs diabetic complications and other autoimmune diseases. The company is headquartered in Jenkintown, PA. | Direktor/Vorstandsmitglied | - | - |
The Philadelphia Foundation
 The Philadelphia Foundation Investment ManagersFinance The Philadelphia Foundation provides asset development and donor services. The company was founded by William Purves Gest on December 20, 1918 and is headquartered in Philadelphia, PA. | Direktor/Vorstandsmitglied | - | - |
Karriereverlauf von Oliver Franklin
Ehemalige bekannte Positionen von Oliver Franklin
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| City of Philadelphia (Pennsylvania) | Corporate Officer/Principal | - | - |
Dynamis Therapeutics, Inc.
 Dynamis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Dynamis Therapeutics, Inc. operates as a holding company with interests in developing pharmaceuticals and diagnostics. It operates through its subsidiaries Dynamis Pharmaceuticals, Inc. and Dynamis Skin Science. The firm's product DYN 15, a drug candidate that prevents the formation of 3DG, a reactive sugar, as well as decreases the levels of key cytokines that are stimulated in chronic inflammations. The company was founded by Annette M. Tobia on May 21, 1997 and is headquartered in Jenkintown, PA. | Direktor/Vorstandsmitglied | 25.01.2010 | - |
Statistik
International
| Vereinigte Staaten | 6 |
| China | 2 |
Operativ
| Director/Board Member | 4 |
| Corporate Officer/Principal | 2 |
| Independent Dir/Board Member | 1 |
Sektoral
| Health Technology | 4 |
| Government | 2 |
| Finance | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| JIN MEDICAL INTERNATIONAL LTD. | Health Technology |
| Private Unternehmen | 5 |
|---|---|
Dynamis Therapeutics, Inc.
Dynamis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Dynamis Therapeutics, Inc. operates as a holding company with interests in developing pharmaceuticals and diagnostics. It operates through its subsidiaries Dynamis Pharmaceuticals, Inc. and Dynamis Skin Science. The firm's product DYN 15, a drug candidate that prevents the formation of 3DG, a reactive sugar, as well as decreases the levels of key cytokines that are stimulated in chronic inflammations. The company was founded by Annette M. Tobia on May 21, 1997 and is headquartered in Jenkintown, PA. | Health Technology |
| International House of Philadelphia | |
| City of Philadelphia (Pennsylvania) | Government |
Dynamis Pharmaceuticals, Inc.
Dynamis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Dynamis Pharmaceuticals, Inc. engages in the research and development of biopharmaceutical products. It develops drugs diabetic complications and other autoimmune diseases. The company is headquartered in Jenkintown, PA. | Health Technology |
The Philadelphia Foundation
The Philadelphia Foundation Investment ManagersFinance The Philadelphia Foundation provides asset development and donor services. The company was founded by William Purves Gest on December 20, 1918 and is headquartered in Philadelphia, PA. | Finance |
- Börse
- Insiders
- Oliver Franklin
- Erfahrung
